Co-Diagnostics, Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
CODX$0.32+24.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Changes in Stockholders’ Equity
| Convertible Preferred Stock · Common Stock · Treasury · Additional Paid-in · Accumulated Other Comprehensive · Accumulated Earnings · Total Stockholders’ | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Stock · Capital · Income · (Deficit) · Equity | ||||||||||
| Balance as of December 31, 2022 | - | $ | - | 34,754,265 | $34,754 | $(14,211,866) | $88,472,935 | $293,140 | $39,931,031 | $114,519,994 |
| Stock-based compensation expense | - | - | 1,354,081 | 1,354 | - | 8,335,501 | - | - | 8,336,855 | |
| Repurchases of common stock | - | - | - | - | (1,363,929) | - | - | - | (1,363,929) | |
| Other comprehensive loss, net of tax | - | - | - | - | - | - | (146,440) | - | (146,440) | |
| Net loss | - | - | - | - | - | - | - | (35,332,865) | (35,332,865) | |
| Balance as of December 31, 2023 | - | $ | - | 36,108,346 | $36,108 | $(15,575,795) | $96,808,436 | $146,700 | $4,598,166 | $86,013,615 |
| Issuance of common stock related to at-the-market offering, net of offering costs | - | - | 314,707 | 315 | - | 230,349 | - | - | 230,664 | |
| Stock-based compensation expense | - | - | 1,479,169 | 1,479 | - | 5,433,425 | - | - | 5,434,904 | |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | |
| Other comprehensive loss, net of tax | - | - | - | - | - | - | 271,743 | - | 271,743 | |
| Net loss | - | - | - | - | - | - | - | (37,639,008) | (37,639,008) | |
| Balance as of December 31, 2024 | - | $ | - | 37,902,222 | $37,902 | $(15,575,795) | $102,472,210 | $418,443 | $(33,040,842) | $54,311,918 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.